Increased perivascular norepinephrine following intracerebroventricular infusion of NGF into adult rats

Experimental Neurology

Volumn 139, Issue 1, 1996, Pages 54-60

  Isaacson, L G ^a   Billieu, S C ^a  

^a MIAMI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BRAIN VENTRICLE; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NERVE CELL PLASTICITY; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029895125     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0080     Document Type: Article

References (30)

1. ANDREWS, T. J., AND T. COWEN. 1994. In vivo infusion of NGF induces the organotypic regrowth of perivascular nerves following their atrophy in aged rats. J. Neurosci. 14: 3048-3058.
2. ANDREWS, T. J., AND T. COWEN. 1994. Nerve growth factor enhances the dendritic arborization of sympathetic ganglion cells undergoing atrophy in aged rats. J. Neurocytol. 23: 234-241.
3. BJERRE, B., A. BJORKLUND, W. MOBLEY, AND E. ROSENGREN. 1975. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse. Brain. Res. 94: 263-277.
4. BUCKHOLTZ, N. S. 1994. Alzheimer's Disease drug development and testing at National Institute on Aging. Psychopharmacol. Bull. 30: 15-17.
5. COCHARD, P., M. GOLDSTEIN, AND I. B. BLACK. 1979. Initial development of the noradrenergic phenotype in autonomic neuroblasts of the rat embryo in vivo. Dev. Biol. 71: 100-114.
6. DINERSTEIN, R. J., J. VANNICE, R. C. HENDERSON, L. J. ROTH, L. I. GOLDBERG, AND P. C. HOFFMANN. 1979. Histofluorescence techniques provide evidence for dopamine containing neuron elements in canine kidney. Science 205: 497-499.
7. EDVINSSON, L., E. T. MACKENZIE, AND J. MCCULLOCH, EDS. 1993. Cerebral Blood Flow and Metabolism, pp. 231-252. Raven Press, New York.
8. FAVARD, C., A. SIMON, AND J. NGUYEN-LEGROS. 1989. Close relationship between dopaminergic varicosities and small blood vessel walls in rat and monkey retina. In Neurotransmission and Cerebrovascular Function (J. Seylaz and E. T. MacKenzie, Eds.), pp. 159-162. Elsevier, Amsterdam.
9. FELTEN, D. L., AND K A. CRUTCHER. 1979. Neuronal-vascular relationships in the raphe nuclei, locus coeruleus and substantia nigra in primates. Am. J. Anat. 155: 467-482.
10. FINLAY, J. M., AND M. J. ZIGMOND. 1995. A critical analysis of neurochemical methods for monitoring transmitter dynamics in the brain. In Psychopharmacology: The Fourth Generation of Progress (F. E. Bloom and D. J. Kupfer, Eds.), pp. 29-40. Raven Press, New York.
11. HEAD, R. J., J. T. HJELLE, B. JARROTT, B. BERKOWITZ, G. CARDINALE AND S. SPECTOR. 1980. Isolated brain microvessels: Preparation, morphology, histamine, and catecholamine contents. Blood Vessels 17: 173-186.
12. ISAACSON, L. G., AND K. A. CRUTCHER. 1990. Intracerebral infusion of NGF induces hyperinnervation of cerebral blood vessels. Neurobiol. Aging 11: 51-55.
13. ISAACSON, L. G., B. N. SAFFRAN, AND K. A. CRUTCHER. 1992. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons. J. Comp. Neurol. 326: 327-336.
14. ISAACSON, L. G., D. ONDRIS, AND K. A. CRUTCHER. 1995. The plasticity of sensory cerebrovascular axons following intracranial infusion of nerve growth factor. J. Comp. Neurol. 361: 451-460.
15. ISAACSON, L. G., AND K. A. CRUTCHER. 1995. The duration of sprouted cerebrovascular axons following intracranial infusion of nerve growth factor. Exp. Neurol. 131: 174-179.
16. LAPCHAK, P., AND F. HEFTI. 1992. Pharmacological actions of recombinant human nerve growth factor on lesioned central cholinergic neurons: Rationale for the treatment of Alzheimer's disease. In Cholinergic Basis for Alzheimer's Therapy. (R. Becker and E. Giacobini, Eds.), pp. 397-403. Birkhauser.
17. LOWRY, O. H., N. J. ROSEBROUGH, A. L. FARR, AND R. J. RANDALL. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
18. OLSON, L. 1993. NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124: 5-15.
19. ONDRIS, D., C. BILLIEU, K. SCHWENK, S. PAGE, AND L. G. ISAACSON. 1994. Nerve Growth Factor-induced plasticity of cerebrovascular innervation. Soc. Neurosci. Abstr. 20: 1093.
20. PHELPS, C. H., F. H. GAGE, J. H. GROWDON, F. HEFTI, R. HARBAUGH, M. V. JOHNSTON, Z. S. KHACHATURIAN, W. C. MOBLEY, D. PRICE, M. RASKIND, J. SIMPKINS, L. THAL, AND J. WOODCOCK. 1989. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol. Aging 10: 205-207.
21. RENNELS, M. L., T. F. GREGORY, O. R. BLAUMANIS, K FUJIMOTO, AND P. A. GRADY. 1985. Evidence for a 'perivascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from subarachnoid space. Brain Res. 326: 47-63.
22. RUBIN, E. 1985. Development of the rat superior cervical ganglion: Ganglion cell maturation. J. Neurosci. 5: 673-684.
23. RUIT, K. G., P. A. OSBORNE, R. E. SCHMIDT, E. M. JOHNSON, JR., AND W. D. SNIDER. 1990. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J. Neurosci. 10: 2412-2419.
24. SAFFRAN, B. N., J. E. WOO, W. C. MOBLEY, AND K. A. CRUTCHER 1989. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res. 492: 245-254.
25. SAFFRAN, B. N., AND K. A. CRUTCHER. 1990. NGF-induced remodeling of uninjured mature axon collaterals. Brain Res. 525: 11-20.
26. SAS INSTITUTE, INC. 1985. SAS User's Guide: Statistics; 5th Edition. 956 pp. Cary, N.C.: SAS Institute, Inc.
27. SEIGER, A., A. NORDBERG, H. VON HOLST, L. BACKMAN, T. EBENDAL, I. ALAFUZOFF, K. AMBERLA, P. HARTVIG, A. HERLITZ, A. LILJA, H. LUNDQVIST, B. LANGSTROM, B. MEYERSON, A. PERSSON, M. VIITANEN, B. WINBLAD, AND L. OLSON. 1993. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: The first attempt of a possible future treatment strategy. Behav. Brain Res. 57: 255-261.
28. TIAN, Y., K. J. LOOKINGLAND, AND K. E. MOORE. 1991. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons. Brain Res. 555: 135-140.
29. TUSZYNSKI, M. H., AND F. H. GAGE. 1994. Neurotrophic factor and diseases of the nervous system. Annals Neurol. Exp. 35: S9-S12.
30. WILLIAMS, L. R., H. L. VAHLSING, T. LINDAMOOD, S. VARON, F. H. GAGE, AND M. MANTHORPE. 1987. A small-gauge cannula device for continuous infusion of exogenous agents into the brain. Exp. Neurol. 95: 743-754.